US Stock MarketDetailed Quotes

MLTX MoonLake Immunotherapeutics

Watchlist
  • 52.170
  • +0.290+0.56%
Close Dec 20 16:00 ET
  • 52.170
  • 0.0000.00%
Post 20:01 ET
3.29BMarket Cap-41.08P/E (TTM)

About MoonLake Immunotherapeutics Company

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

Company Profile

SymbolMLTX
Company NameMoonLake Immunotherapeutics
Listing DateOct 20, 2020
Founded2021
CEODr. Jorge Santos da Silva
MarketNASDAQ
Employees50
Fiscal Year Ends12-31
AddressDorfstrasse 29
CityZug
ProvinceZug
CountrySwitzerland
Zip Code6300
Phone41-510-80-22
Websitehttp://www.moonlaketx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jorge Santos da Silva
  • Chief Executive Officer and Director
  • 1.20M
  • Matthias Bodenstedt
  • Chief Financial Officer and Principal Accounting Officer
  • 891.60K
  • Dr. Kristian Reich
  • Chief Scientific Officer
  • 1.23M
  • Simon John Sturge
  • Chairman of the Board
  • 315.49K
  • Catherine Moukheibir
  • Independent Director
  • 287.49K
  • Spike Loy
  • Independent Director
  • 277.49K
  • Dr. Ramnik Xavier
  • Independent Director
  • 299.99K
  • Dr. Andrew Phillips, PhD
  • Independent Director
  • 280.99K
  • Dr. Kara Lassen
  • Independent Director
  • 44.00K
Heat List
US
Overall
Symbol
Price
% Chg

No Data